Eur Respir J 2002; 19:1114-1118
Copyright ©ERS Journals Ltd 2002
Survival of patients with biopsy-proven usual interstitial pneumonia and nonspecific interstitial pneumonia
R.L. Riha1,
E.E. Duhig2,
B.E. Clarke2,
R.H. Steele3,
R.E. Slaughter1 and
P.V. Zimmerman1
1 Thoracic and Radiology Dept and 2 Pathology Dept, The Prince Charles Hospital and 3 Pathology Dept, The Princess Alexandra Hospital, Brisbane, Australia
CORRESPONDENCE: R.L. Riha, Dept of Medicine, The University of Edinburgh, Royal Infirmary, Lauriston Place, Edinburgh, EH3 9YW. Fax: 44 1315362362. E-mail: R.L.Riha@ed.ac.uk
Keywords: Idiopathic interstitial pneumonia, idiopathic pulmonary fibrosis, survival, usual interstitial pneumonia
Received: May 10, 2001
Accepted December 10, 2001
This is the first Australian study to examine survival and clinical characteristics in biopsy-proven idiopathic interstitial pneumonia.
A cohort of 70 patients from a single institution between January 1990 and December 1999 was reviewed.
All patients were Caucasian, 23 (33%) female. Mean age±sd at diagnosis was 60±12 yrs for males and 54±14 yrs for females. A total 24% of patients had never smoked. The histopathological diagnoses were usual interstitial pneumonia (UIP) (n=59), nonspecific interstitial pneumonia (NSIP) (n=7), desquamative interstitial pneumonia (n=3) and acute interstitial pneumonia (n=11). Clinical and functional characteristics of the two main histological subgroups of UIP and NSIP showed significantly older patients in the UIP group and a significantly lower mean forced expiratory volume in one second (FEV1) in the NSIP group. Median survival for UIP was 78 months compared with 178 months for NSIP. No survival difference between treated and untreated patients with UIP was found. Multivariate analysis revealed smoking alone to be predictive of poorer survival.
This study demonstrates the best median survival for usual interstitial pneumonia of available series and confirms a survival difference between usual interstitial pneumonia and nonspecific interstitial pneumonia. Furthermore, the reported results may have implications for treatment timing using conventional protocols currently recommended.
This article has been cited by other articles:

|
 |

|
 |
 
K. M. Shin, K. S. Lee, M. P. Chung, J. Han, Y. A Bae, T. S. Kim, and M. J. Chung
Prognostic Determinants among Clinical, Thin-Section CT, and Histopathologic Findings for Fibrotic Idiopathic Interstitial Pneumonias: Tertiary Hospital Study
Radiology,
October 1, 2008;
249(1):
328 - 337.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A U Wells, N Hirani, and on behalf of the BTS Interstitial Lung Disease Gui
Interstitial lung disease guideline
Thorax,
September 1, 2008;
63(Suppl_5):
v1 - v58.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. J. Scotton and R. C. Chambers
Molecular Targets in Pulmonary Fibrosis: The Myofibroblast in Focus
Chest,
October 1, 2007;
132(4):
1311 - 1321.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Mueller-Mang, C. Grosse, K. Schmid, L. Stiebellehner, and A. A. Bankier
What Every Radiologist Should Know about Idiopathic Interstitial Pneumonias
RadioGraphics,
May 1, 2007;
27(3):
595 - 615.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. H. Park, D. S. Kim, I-N. Park, S. J. Jang, M. Kitaichi, A. G. Nicholson, and T. V. Colby
Prognosis of Fibrotic Interstitial Pneumonia: Idiopathic versus Collagen Vascular Disease-related Subtypes
Am. J. Respir. Crit. Care Med.,
April 1, 2007;
175(7):
705 - 711.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E. Kreider, J. Hansen-Flaschen, N. N. Ahmad, M. D. Rossman, L. R. Kaiser, J. C. Kucharczuk, and J. B. Shrager
Complications of Video-Assisted Thoracoscopic Lung Biopsy in Patients with Interstitial Lung Disease
Ann. Thorac. Surg.,
March 1, 2007;
83(3):
1140 - 1144.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S J Bourke
Interstitial lung disease: progress and problems.
Postgrad. Med. J.,
August 1, 2006;
82(970):
494 - 499.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. J. Martinez
Idiopathic Interstitial Pneumonias: Usual Interstitial Pneumonia versus Nonspecific Interstitial Pneumonia.
Proceedings of the ATS,
January 1, 2006;
3(1):
81 - 95.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. J. Martinez and K. Flaherty
Pulmonary function testing in idiopathic interstitial pneumonias.
Proceedings of the ATS,
January 1, 2006;
3(4):
315 - 321.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Walter, H. R. Collard, and T. E. King Jr.
Current perspectives on the treatment of idiopathic pulmonary fibrosis.
Proceedings of the ATS,
January 1, 2006;
3(4):
330 - 338.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Tiitto, U. Heiskanen, R. Bloigu, P. Paakko, V. Kinnula, and R. Kaarteenaho-Wiik
Thoracoscopic Lung Biopsy Is a Safe Procedure in Diagnosing Usual Interstitial Pneumonia
Chest,
October 1, 2005;
128(4):
2375 - 2380.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Jegal, D. S. Kim, T. S. Shim, C.-M. Lim, S. Do Lee, Y. Koh, W. S. Kim, W. D. Kim, J. S. Lee, W. D. Travis, et al.
Physiology Is a Stronger Predictor of Survival than Pathology in Fibrotic Interstitial Pneumonia
Am. J. Respir. Crit. Care Med.,
March 15, 2005;
171(6):
639 - 644.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. F. Nadrous, J. L. Myers, P. A. Decker, and J. H. Ryu
Idiopathic Pulmonary Fibrosis in Patients Younger Than 50 Years
Mayo Clin. Proc.,
January 1, 2005;
80(1):
37 - 40.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
H. R. Collard, J. H. Ryu, W. W. Douglas, M. I. Schwarz, D. Curran-Everett, T. E. King Jr., and K. K. Brown
Combined Corticosteroid and Cyclophosphamide Therapy Does Not Alter Survival in Idiopathic Pulmonary Fibrosis
Chest,
June 1, 2004;
125(6):
2169 - 2174.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Fujimoto, T. Okazaki, T. Matsukura, T. Hanawa, N. Yamashita, K. Nishimura, M. Kuwabara, and Y. Matsubara
Operation for lung cancer in patients with idiopathic pulmonary fibrosis: surgical contraindication?
Ann. Thorac. Surg.,
November 1, 2003;
76(5):
1674 - 1678.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the European Respiratory Society.
|